Talking the Cure by Hogan Lovells
Episodes
It’s a Brave New World: Pharma ad/promo enforcement is changing in the U.S. and Europe, and companies should, too
20 Oct 2025
Contributed by Lukas
FDA’s recent splash of 100+ enforcement letters objecting to drug advertising looks like a trend, not a blip. And although the UK and EU prohibit ...
The future of drug pricing: IRA, MFN, and tariff pressures explained
22 Sep 2025
Contributed by Lukas
In this episode of Talking the Cure, Hogan Lovells partners Phil Katz, Alice Valder Curren, and Jane Summerfield discuss the evolving landscape of pha...
AI at the crossroads: Global developments shaping life sciences
29 Jul 2025
Contributed by Lukas
In this episode of Talking the Cure, Hogan Lovells partners Phil Katz, Melissa Bianchi, and Jodi Scott explore how artificial intelligence is transfor...
Planning the Pivot: Onshoring Pharma/Biotech Manufacturing in a Brave New World
09 Jun 2025
Contributed by Lukas
Starting with tariffs and Executive Orders, there are myriad incentives – some would say imperatives – for pharma and biotech companies to increas...
A cure worse than the disease? Using tariffs to bolster U.S. pharma manufacturing
09 May 2025
Contributed by Lukas
In this episode of Talking the Cure, Phil Katz talks with Cybil Roehrenbeck, Josh Gelula, and Kelly Zhang about the announced and seemingly ever-chang...
Pharma – The Last Word – Breaking Barriers: The FDA’s Evolving Approach to Biosimilars and Interchangeability
25 Sep 2024
Contributed by Lukas
In this episode, host Phil Katz sits down with Deborah Cho, to discuss the evolving landscape of biosimilarity and interchangeability. They dive into ...
Drafting the Future: Unpacking the FDA's Clinical Trial Diversity Action Plan
12 Jul 2024
Contributed by Lukas
In the third part of our clinical trial diversity series, Deborah Cho, Stephanie Agu, and Ashley Grey dissect FDA's new draft guidance on Diversity Ac...
Pharma – The Last Word – Early Access Unlocked, navigating EU programs for pre-approval drug access
28 Jun 2024
Contributed by Lukas
In this episode Phil Katz and Hein van den Bos discuss early access programs in the EU, exploring the various types of programs, their practical impli...
Pharma – The Last Word – Regulatory and legal trends in the pharma and biotech industries
31 May 2024
Contributed by Lukas
In this episode host Phil Katz, discusses regulatory and legal trends in the pharma and biotech industries with Komal Karnik Nigam. They delve into th...
Pharma – The Last Word - The inaugural episode
29 Apr 2024
Contributed by Lukas
Welcome to the inaugural episode of "Pharma – The Last Word", a podcast hosted by Partner Phil Katz from Hogan Lovells. This series aims to dive in...
Securing the Crown Jewels: Navigating IP and cybersecurity in the life science industry
11 Apr 2024
Contributed by Lukas
In this episode of Talking the Cure Hogan Lovells Life Sciences and Health Care Podcast Ruud van der Velden and Chantal Van Dam highlight the importan...
Discussing UK medical device regulations
21 Mar 2024
Contributed by Lukas
In this episode Jane Summerfield and Owen Robinson discuss UK medical device regulation, focusing on the regulatory roadmap published by the MHRA, its...
Talking the Cure - Exploring the industry with Richard Backhaus and Lars Cornels (Drägerwerk AG & Co. KGaA) - Part 2
29 Feb 2024
Contributed by Lukas
In the second part of the episode, Arne Thiermann is leading the conversation with Richard Backhaus, and Lars Cornels...
Talking the Cure - Exploring the industry with Richard Backhaus and Lars Cornels (Drägerwerk AG & Co. KGaA) - Part 1
12 Feb 2024
Contributed by Lukas
In this first part of the episode, Arne Thiermann is leading the conversation with Richard Backhaus, and Lars Cornels discussing the integration and i...
Talking the Cure - Exploring the industry with Robert F. Church
24 Jan 2024
Contributed by Lukas
In this episode, Robert F. Church takes the time to look back on his career with us. We talk about what ultimately led him to become a lawyer, how ...
Talking the Cure - Exploring the industry with Alice Valder Curran
16 Nov 2023
Contributed by Lukas
In this episode, Alice Valder Curran sits down with us to talk about her impressive career, why she ultimately chose Hogan Lovells as her employer, an...
Talking the Cure - Exploring the industry with Randy Prebula
23 Oct 2023
Contributed by Lukas
In this episode, Randy Prebular sits down with us and we talk about his impressive professional career, how he actually wanted to be a pediatrician at...
Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)
28 Sep 2023
Contributed by Lukas
In this podcast episode, Alice Curran and Cullen Taylor discuss the implications of the Inflation Reduction Act (IRA) on the life sciences and healthc...
Talking the Cure - Discussing latest developments іn clinical trials diversity, driven by FDORA
06 Sep 2023
Contributed by Lukas
In this episode оf 'Talking the Cure,' we dive into the latest developments іn clinical trials diversity, driven by the Food and Drug Om...
Talking the Cure - Discussing Artificial Intelligence in Medical Devices
26 Jan 2023
Contributed by Lukas
Arne Thiermann and Nicole Saurin talk about the current state and development of artificial intelligence in the medical device industry. How will AI m...
Talking the Cure - Discussing MedTech Color with Kwame Ulmer
13 Nov 2022
Contributed by Lukas
In this episode, Beth L. Roberts (Partner, Washington, D.C.) is talking to Kwame Ulmer (Founder and Executive Director) about MedTech Color, its missi...
Talking the Cure - Exploring the industry with Ina Brock
27 Sep 2022
Contributed by Lukas
In this episode, Ina Brock invites us to her home and tells us that she actually wanted to become a journalist, but chance brought her to law. And the...
Talking the Cure - Discussing diversity in clinical trials
28 Jul 2022
Contributed by Lukas
Robert F. Church, Sarah Thompson Schick, Stephanie Agu, and Akosua Tuffuor, J.D. discuss recent developments in FDA’s and industry’s approaches t...
Talking the Cure - Discussing the repurpose of existing UK offices/retail to laboratory space?
20 Jun 2022
Contributed by Lukas
What to expect if you want to repurpose existing UK real estate, in particular, offices/retail to laboratory space? Graham Cutts will give an overview...
Talking the Cure - Discussing what’s on the horizons for orthopedic devices
18 May 2022
Contributed by Lukas
What’s on the horizons for orthopedic devices? In this episode, Michael Kasser and Jemin Jay Dedania talk about their journey in the field of orthop...
Talking the Cure - Exploring the industry with Andreas von Falck
13 Apr 2022
Contributed by Lukas
In this episode, Andreas von Falck will tell us that he actually wanted to work for an NGO, but then followed his father’s path and became one of th...
Talking the Cure: Discussing Digital Health Applications in Germany
23 Mar 2022
Contributed by Lukas
In this episode, Dr. Victor Stephani, Chief Of Staff at the German digital health high flyer HelloBetter, and Arne Thiermann, a life sciences partner...
Talking the Cure - Exploring the industry with Jonathan S. Kahan
02 Mar 2022
Contributed by Lukas
In the first episodes of Season 3, Jonathan S. Kahan, partner and passionate lawyer in the Medical Device and Technology Regulatory practice, took the...
Talking the Cure: Discussing Early Access Programs (EAPs) in the US and Germany
16 Dec 2021
Contributed by Lukas
In this episode, I talk with Dr. Tina Welter-Birk and Komal Karnik Nigam about the Early Access Programs (EAPs), known as Expanded Access Programs in ...
Talking The Cure: Exploring the industry with Christian Di Mauro
01 Dec 2021
Contributed by Lukas
In this episode, Christian Di Mauro, who is heading the Italian litigation and arbitration practice talk about his 17 years of experience working with...
Talking The Cure: Discussing return to work policies, testing at work sites, and vaccinations
06 Jul 2021
Contributed by Lukas
In this episode, Thierry Meillat, Stefan Martin, Eckard Schwarz, and Zachary Siegel talked about the various return to work policies, testing at work ...
Talking The Cure: Exploring the industry with Lowell Zeta
15 Jun 2021
Contributed by Lukas
In this episode, Lowell M. Zeta, who just rejoined the firm after serving as Senior Counselor to the Commissioner at FDA, is going to talk to Philip K...
Talking The Cure: Discussing the impact of Covid-19 on cell, tissue, and gene therapy products
06 May 2021
Contributed by Lukas
In this episode, I talk with Michael Druckman, Jane Kalinina and Bert Lao about the the impact of Covid-19 on cell, tissue, and gene therapy products...
Talking The Cure: Discussing advertising and promotion of COVID-19 test kits
15 Apr 2021
Contributed by Lukas
In this episode, I talk with Suzanne Levy Friedman and Michael Penners about how both U.S. and Germany have seen a lot of legal/regulatory activity...
Talking The Cure: Discussing hand sanitizers and their way to the market
08 Mar 2021
Contributed by Lukas
In this episode, I talk with David Horowitz about his work around bringing hand sanitizers onto the market in the US. Understanding FDA’s expectatio...
Talking The Cure: Discussing the current ”surge” of Digital Health Innovations in Europe
16 Feb 2021
Contributed by Lukas
In this episode, I talk with Fabien Roy and Jonas Albert about the current "surge" of Digital Health Innovations in Europe, receiving the CE-Marking,...
Talking The Cure: Exploring the industry with Jodi Scott
21 Jan 2021
Contributed by Lukas
In this episode, Jodi Scott, a partner at Hogan Lovells in Denver, is going to talk about her time spent as an in-house FDA counsel with the world's l...
Talking The Cure: Exploring the industry with the leads of our associate committee
21 Dec 2020
Contributed by Lukas
In this episode, I talk with Jeff Jay and Tina Welter about their involvement in the life sciences and health care associate committee. This position ...
Talking The Cure: Discussing artificial intelligence in drug discovery and the possible legal issues that result from this usage.
03 Dec 2020
Contributed by Lukas
In this episode, Jason Lohr and Imogen Ireland, are going to explore some interesting questions to do with whether or not patent law is set up to deal...
Talking The Cure: Discussing in vitro diagnostics (IVD) in times of a pandemic
13 Nov 2020
Contributed by Lukas
In this episode, Randy J. Prebula, Susan D. Tiedy-Stevenson, and Erkang Ai, Ph.D. are talking about the “world” of what is considered to be in in-...
Talking The Cure: Exploring the industry with Jonathan Wasserman
21 Oct 2020
Contributed by Lukas
Jon Wasserman, a new partner at Hogan Lovells and former Bristol Myers Squibb vice president, is going to talk about his past, the state of the indust...
Talking The Cure: Discussing the “Buy America” Executive Order
12 Oct 2020
Contributed by Lukas
On August 6, 2020, U.S. President Donald Trump issued his much-anticipated "Buy American" Executive Order (EO), aimed at shoring up domestic manufac...
Talking The Cure: Discussing opportunities and risks for international digital health companies engaging in Germany
12 Oct 2020
Contributed by Lukas
In this episode, Arne Thiermann and Dr. Julian Braun, director of legal at Heartbeat Labs, discuss the opportunities and risks for international co...
Talking The Cure: Discussing innovation in drug development, the competitive aspects and affordability of medicines in Europe
12 Oct 2020
Contributed by Lukas
In this episode, May Lyn Yuen and Hein Van den Bos discuss the balance of innovation in drug development, the competitive aspects and affordability...
Talking The Cure: Discussing recent industry developments with the Hogan Lovells Sciences Unit
12 Oct 2020
Contributed by Lukas
In our latest episode, you will get to know members of our Science Unit Dr. Marion Palmer and Dr. Rachel Gribben, who talk about their experience w...
Talking The Cure: Discussing the rise of telehealth in the life sciences and health care industry
12 Oct 2020
Contributed by Lukas
In this episode, our partners Brooke Bumpers and William Ferreira talk about the growth of the telehealth industry during the COVID-19 pandemic and...
Talking The Cure: Exploring the industry with Philip Katz - Part 2
12 Oct 2020
Contributed by Lukas
In the second part of our two-part interview with Philip Katz, head of the Hogan Lovells Pharmaceuticals and Biotechnology Regulatory Practice, we di...
Talking The Cure: Exploring the industry with Philip Katz - Part 1
12 Oct 2020
Contributed by Lukas
In the first episode of our two-part interview with Philip Katz, head of the Hogan Lovells Pharmaceuticals and Biotechnology Regulatory Practice, we ...
Talking the Cure: Discussing venture capital in the life sciences and health care sector in Germany
12 Oct 2020
Contributed by Lukas
In this episode, our partners Jörg Schickert and Nikolas Zirngibl talk with Jörn Bungartz, an adviser in the digital health sector, about opport...
Talking The Cure: Discussing European developments on Covid-19
12 Oct 2020
Contributed by Lukas
In this episode, Elisabethann Wright, Jane Summerfield, and Hein Van den Bos talk about developments in Belgium, the UK, and the Netherlands and ho...
Talking The Cure: Discussing reimbursement issues in France and the MDR
12 Oct 2020
Contributed by Lukas
In this episode, Charlotte Damiano and Fabien Roy talk about reimbursement issues, early access and the collection of clinical data in France. In ...
Talking the Cure: Discussing COVID-19’s impact on FDA’s inspection program and next steps after the pandemic
12 Oct 2020
Contributed by Lukas
In this episode, Phil Katz and Jim Johnson continue their conversation about the impact of COVID-19 on FDA’s drug inspection program and the ste...
Talking The Cure: Discussing how the coronavirus pandemic is affecting the pharmaceutical industry and FDA
12 Oct 2020
Contributed by Lukas
In this episode, Phil Katz, David Horowitz, and Jim Johnson explore the impact on industry and FDA of the agency’s decision to halt foreign inspe...
Talking The Cure: Discussing FDA authorities for handling a global pandemic for medical devices
12 Oct 2020
Contributed by Lukas
In this episode, Michael S. Heyl and Jonathan S. Kahan explore questions around FDA’s Emergency Use Authorization authorities, how it has been used ...
Talking the Cure: Discussing the supply chain and its potential downfalls
12 Oct 2020
Contributed by Lukas
In this episode, Arne Thiermann and Mike Druckman explore questions around the supply chain in the life sciences and health care industry. They highli...
Talking The Cure: Exploring the industry with Jörg Schickert
12 Oct 2020
Contributed by Lukas
In this episode, Jörg Schickert, one of the leading life sciences and health care lawyers for regulatory and commercial issues in Europe, is going to...
Talking The Cure: Discussing the use of digital tools in clinical trials
12 Oct 2020
Contributed by Lukas
In this episode, Elisabethann Wright and Robert F. Church from our Global Regulatory practice explore questions around the use of digital tools in cli...